Table 1 Some demographic and clinical data observed in the whole group of DTC subjects and in controls.
| Â | DTC subjects | Control subjects | Significance |
|---|---|---|---|
Age (years) | 57.0 ± 13.7 | 56.5 ± 15.9 | ns |
Sex (male-to-female ratio) | 4 : 1 | 9 : 1 | ns |
Mean diagnosis-study interval (years) | 7.0 ± 0.6 | 9.5 ± 1.0 | ns |
L-T4 dosage (μg/week) | 863 ± 17 | 658 ± 26 | P < 0.0001 |
BMI (kg/m2) | 27.0 ± 0.5 | 25.6 ± 0.4 | ns |
Systolic blood pressure (mmHg) | 128 ± 2 | 129 ± 2 | ns |
Diastolic blood pressure (mmHg) | 82 ± 1 | 80 ± 1 | ns |
Hypertension | 59 (56%) | 46 (53%) | ns |
Use of antihypertensive drugs | 53 (50%) | 39 (45%) | ns |
Diabetes mellitus | 5 (5%) | 7 (8%) | ns |
Use of antidiabetic drugs | 4 (4%) | 4 (5%) | ns |
Use of dyslipidemia drugs | 8 (7%) | 6 (7%) | ns |
Smokers | 30 (28%) | 35 (40%) | ns |
   Current smokers | 13 (12%) | 17 (19%) | - |
   Former smokers | 17 (16%) | 18 (21%) | - |
History of myocardial infarction | 0 (0%) | 0 (0%) | ns |
History of stroke | 0 (0%) | 0 (0%) | ns |